Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physician Assistants | 13 | 2023 | 41 | 8.940 |
Why?
|
| Students, Pharmacy | 10 | 2021 | 11 | 4.960 |
Why?
|
| Education, Pharmacy | 10 | 2021 | 13 | 4.430 |
Why?
|
| Asthma | 16 | 2023 | 397 | 3.750 |
Why?
|
| Communication | 7 | 2017 | 122 | 2.610 |
Why?
|
| Educational Measurement | 7 | 2022 | 111 | 2.470 |
Why?
|
| Caregivers | 9 | 2017 | 94 | 2.380 |
Why?
|
| Physicians | 3 | 2023 | 134 | 2.300 |
Why?
|
| Pharmaceutical Services | 4 | 2021 | 6 | 2.280 |
Why?
|
| Anti-Asthmatic Agents | 8 | 2023 | 71 | 2.010 |
Why?
|
| Pharmacists | 6 | 2021 | 17 | 2.000 |
Why?
|
| Patient Education as Topic | 7 | 2017 | 251 | 1.970 |
Why?
|
| Patient Simulation | 3 | 2017 | 30 | 1.820 |
Why?
|
| Humans | 64 | 2024 | 29093 | 1.820 |
Why?
|
| Medicine | 2 | 2023 | 30 | 1.770 |
Why?
|
| Drug Prescriptions | 3 | 2022 | 52 | 1.700 |
Why?
|
| Cross-Sectional Studies | 14 | 2023 | 1356 | 1.650 |
Why?
|
| Community Pharmacy Services | 3 | 2020 | 3 | 1.620 |
Why?
|
| Medicare Part D | 3 | 2021 | 8 | 1.610 |
Why?
|
| Suicide | 3 | 2020 | 17 | 1.600 |
Why?
|
| Attitude of Health Personnel | 3 | 2023 | 162 | 1.480 |
Why?
|
| Problem-Based Learning | 3 | 2018 | 26 | 1.420 |
Why?
|
| Students | 6 | 2023 | 168 | 1.380 |
Why?
|
| Professional-Patient Relations | 3 | 2017 | 21 | 1.370 |
Why?
|
| Analgesics, Opioid | 5 | 2023 | 239 | 1.150 |
Why?
|
| Medication Adherence | 3 | 2018 | 144 | 1.140 |
Why?
|
| Curriculum | 6 | 2023 | 196 | 1.100 |
Why?
|
| Child | 17 | 2023 | 2219 | 1.070 |
Why?
|
| Nebulizers and Vaporizers | 6 | 2023 | 13 | 1.040 |
Why?
|
| Physical Examination | 2 | 2023 | 82 | 1.030 |
Why?
|
| Self Care | 3 | 2017 | 137 | 1.020 |
Why?
|
| Hypertension | 2 | 2022 | 906 | 0.950 |
Why?
|
| Adolescent | 15 | 2022 | 3254 | 0.950 |
Why?
|
| Pharmacies | 2 | 2021 | 11 | 0.950 |
Why?
|
| Primary Health Care | 5 | 2024 | 178 | 0.940 |
Why?
|
| Prostate-Specific Antigen | 1 | 2023 | 61 | 0.910 |
Why?
|
| Legislation, Drug | 2 | 2019 | 7 | 0.900 |
Why?
|
| Nurse Practitioners | 1 | 2022 | 9 | 0.880 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 50 | 0.850 |
Why?
|
| Sexually Transmitted Diseases | 1 | 2022 | 37 | 0.840 |
Why?
|
| Clinical Competence | 8 | 2023 | 307 | 0.830 |
Why?
|
| Education, Medical | 1 | 2022 | 67 | 0.820 |
Why?
|
| Suicide, Attempted | 1 | 2021 | 29 | 0.820 |
Why?
|
| Burnout, Professional | 1 | 2022 | 44 | 0.810 |
Why?
|
| Healthcare Disparities | 1 | 2023 | 153 | 0.790 |
Why?
|
| Professional Role | 2 | 2020 | 19 | 0.790 |
Why?
|
| Prescription Drugs | 1 | 2021 | 14 | 0.780 |
Why?
|
| Physician-Patient Relations | 6 | 2015 | 169 | 0.770 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2021 | 84 | 0.770 |
Why?
|
| Female | 26 | 2023 | 18164 | 0.770 |
Why?
|
| Male | 24 | 2023 | 17807 | 0.740 |
Why?
|
| Legislation, Pharmacy | 1 | 2019 | 1 | 0.730 |
Why?
|
| Students, Medical | 1 | 2021 | 121 | 0.730 |
Why?
|
| Internship and Residency | 1 | 2023 | 283 | 0.700 |
Why?
|
| Students, Health Occupations | 1 | 2019 | 5 | 0.690 |
Why?
|
| United States | 9 | 2022 | 3630 | 0.680 |
Why?
|
| Health Knowledge, Attitudes, Practice | 3 | 2020 | 326 | 0.680 |
Why?
|
| Interprofessional Relations | 1 | 2019 | 47 | 0.680 |
Why?
|
| Metered Dose Inhalers | 2 | 2016 | 5 | 0.670 |
Why?
|
| Pharmacy | 1 | 2018 | 1 | 0.670 |
Why?
|
| United States Indian Health Service | 1 | 2018 | 1 | 0.660 |
Why?
|
| Prostatic Neoplasms | 1 | 2023 | 441 | 0.660 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 45 | 0.650 |
Why?
|
| Patient Care Team | 1 | 2019 | 124 | 0.640 |
Why?
|
| Hyperlipidemias | 1 | 2018 | 50 | 0.630 |
Why?
|
| Bronchodilator Agents | 2 | 2016 | 82 | 0.630 |
Why?
|
| Motivation | 1 | 2017 | 102 | 0.590 |
Why?
|
| School Admission Criteria | 1 | 2016 | 11 | 0.580 |
Why?
|
| Quality of Life | 1 | 2022 | 816 | 0.560 |
Why?
|
| North Carolina | 10 | 2019 | 1423 | 0.560 |
Why?
|
| Learning | 4 | 2022 | 76 | 0.550 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 2015 | 10 | 0.540 |
Why?
|
| Bone Density Conservation Agents | 1 | 2015 | 20 | 0.540 |
Why?
|
| Cardiovascular Diseases | 1 | 2022 | 1013 | 0.530 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 366 | 0.510 |
Why?
|
| Polypharmacy | 1 | 2014 | 20 | 0.500 |
Why?
|
| Aged | 11 | 2022 | 9487 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2022 | 1379 | 0.480 |
Why?
|
| Health Services | 1 | 2014 | 35 | 0.480 |
Why?
|
| Health Personnel | 2 | 2014 | 111 | 0.480 |
Why?
|
| Self Efficacy | 5 | 2022 | 70 | 0.460 |
Why?
|
| Adult | 15 | 2023 | 8420 | 0.460 |
Why?
|
| Patient Care Planning | 1 | 2013 | 53 | 0.450 |
Why?
|
| Faculty | 2 | 2023 | 15 | 0.450 |
Why?
|
| Attitude | 2 | 2022 | 37 | 0.420 |
Why?
|
| Job Satisfaction | 2 | 2022 | 37 | 0.420 |
Why?
|
| Pediatrics | 4 | 2014 | 132 | 0.410 |
Why?
|
| Spirometry | 1 | 2011 | 32 | 0.400 |
Why?
|
| Emigrants and Immigrants | 2 | 2023 | 235 | 0.380 |
Why?
|
| Reproducibility of Results | 2 | 2022 | 726 | 0.370 |
Why?
|
| Aged, 80 and over | 5 | 2022 | 3717 | 0.360 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 222 | 0.340 |
Why?
|
| Mental Health | 2 | 2020 | 104 | 0.330 |
Why?
|
| Decision Making | 1 | 2010 | 180 | 0.330 |
Why?
|
| Pilot Projects | 3 | 2022 | 469 | 0.300 |
Why?
|
| Middle Aged | 10 | 2023 | 10829 | 0.300 |
Why?
|
| Linear Models | 2 | 2018 | 426 | 0.290 |
Why?
|
| Administration, Inhalation | 3 | 2016 | 92 | 0.280 |
Why?
|
| Universities | 2 | 2017 | 142 | 0.280 |
Why?
|
| Social Identification | 2 | 2023 | 9 | 0.280 |
Why?
|
| Qualitative Research | 2 | 2017 | 142 | 0.270 |
Why?
|
| Heartburn | 1 | 2024 | 4 | 0.250 |
Why?
|
| Gastroesophageal Reflux | 1 | 2024 | 25 | 0.240 |
Why?
|
| Prescriptions | 1 | 2023 | 9 | 0.240 |
Why?
|
| Professional-Family Relations | 2 | 2013 | 15 | 0.240 |
Why?
|
| Rectum | 1 | 2023 | 15 | 0.230 |
Why?
|
| Accreditation | 1 | 2023 | 14 | 0.230 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2023 | 43 | 0.230 |
Why?
|
| Prenatal Care | 1 | 2023 | 46 | 0.230 |
Why?
|
| Retrospective Studies | 5 | 2020 | 3111 | 0.230 |
Why?
|
| Heart Sounds | 1 | 2022 | 1 | 0.220 |
Why?
|
| Peak Expiratory Flow Rate | 2 | 2013 | 15 | 0.220 |
Why?
|
| Socialization | 1 | 2022 | 4 | 0.220 |
Why?
|
| Models, Statistical | 2 | 2013 | 163 | 0.220 |
Why?
|
| Heart Auscultation | 1 | 2022 | 3 | 0.210 |
Why?
|
| Education, Medical, Graduate | 1 | 2023 | 116 | 0.210 |
Why?
|
| Environmental Exposure | 2 | 2014 | 87 | 0.210 |
Why?
|
| Continuity of Patient Care | 1 | 2022 | 64 | 0.210 |
Why?
|
| Psychometrics | 1 | 2022 | 129 | 0.210 |
Why?
|
| Peer Group | 1 | 2021 | 41 | 0.210 |
Why?
|
| Schools, Pharmacy | 2 | 2019 | 2 | 0.200 |
Why?
|
| Workplace | 1 | 2022 | 47 | 0.200 |
Why?
|
| Data Collection | 1 | 2022 | 163 | 0.200 |
Why?
|
| Patient Preference | 2 | 2023 | 38 | 0.200 |
Why?
|
| Women's Health | 1 | 2022 | 226 | 0.190 |
Why?
|
| Postmenopause | 1 | 2022 | 397 | 0.190 |
Why?
|
| Evidence-Based Medicine | 1 | 2022 | 207 | 0.190 |
Why?
|
| Intestinal Diseases | 1 | 2020 | 18 | 0.190 |
Why?
|
| Severity of Illness Index | 3 | 2013 | 863 | 0.180 |
Why?
|
| Licensure, Pharmacy | 1 | 2019 | 1 | 0.180 |
Why?
|
| Socioeconomic Factors | 2 | 2012 | 391 | 0.180 |
Why?
|
| Jurisprudence | 1 | 2019 | 7 | 0.180 |
Why?
|
| Mass Screening | 2 | 2019 | 223 | 0.180 |
Why?
|
| Liver Diseases | 1 | 2020 | 61 | 0.180 |
Why?
|
| Feedback | 1 | 2019 | 33 | 0.180 |
Why?
|
| Thinking | 1 | 2019 | 6 | 0.180 |
Why?
|
| First Aid | 1 | 2018 | 6 | 0.170 |
Why?
|
| Education, Pharmacy, Continuing | 1 | 2018 | 2 | 0.170 |
Why?
|
| Harm Reduction | 1 | 2018 | 11 | 0.170 |
Why?
|
| Medication Therapy Management | 1 | 2018 | 12 | 0.160 |
Why?
|
| Health Policy | 1 | 2018 | 79 | 0.160 |
Why?
|
| Counseling | 1 | 2018 | 85 | 0.160 |
Why?
|
| Drug Dosage Calculations | 1 | 2017 | 7 | 0.150 |
Why?
|
| Cost-Benefit Analysis | 1 | 2017 | 159 | 0.150 |
Why?
|
| Emergency Medicine | 1 | 2018 | 117 | 0.150 |
Why?
|
| Risk Factors | 2 | 2021 | 3531 | 0.150 |
Why?
|
| Depression | 1 | 2019 | 380 | 0.140 |
Why?
|
| Demography | 1 | 2016 | 104 | 0.140 |
Why?
|
| Inhalation Spacers | 1 | 2016 | 1 | 0.140 |
Why?
|
| West Virginia | 1 | 2015 | 8 | 0.140 |
Why?
|
| Patient Compliance | 1 | 2017 | 208 | 0.140 |
Why?
|
| Internal-External Control | 1 | 2015 | 15 | 0.140 |
Why?
|
| Drug Delivery Systems | 1 | 2016 | 92 | 0.130 |
Why?
|
| Drug Administration Schedule | 1 | 2015 | 246 | 0.130 |
Why?
|
| Lung | 1 | 2016 | 233 | 0.130 |
Why?
|
| Professional Practice | 1 | 2014 | 23 | 0.130 |
Why?
|
| Research Design | 1 | 2016 | 286 | 0.130 |
Why?
|
| Terminology as Topic | 1 | 2014 | 62 | 0.120 |
Why?
|
| Methylmercury Compounds | 1 | 2014 | 7 | 0.120 |
Why?
|
| Nervous System | 1 | 2014 | 15 | 0.120 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 19 | 0.120 |
Why?
|
| Research | 1 | 2014 | 72 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2015 | 148 | 0.120 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2013 | 28 | 0.120 |
Why?
|
| Respiratory Function Tests | 1 | 2013 | 111 | 0.120 |
Why?
|
| Patients | 1 | 2013 | 46 | 0.110 |
Why?
|
| Prospective Studies | 1 | 2018 | 2019 | 0.110 |
Why?
|
| Time Factors | 1 | 2018 | 2001 | 0.110 |
Why?
|
| Risk | 1 | 2013 | 289 | 0.110 |
Why?
|
| Parents | 1 | 2013 | 120 | 0.110 |
Why?
|
| Observer Variation | 1 | 2012 | 96 | 0.110 |
Why?
|
| Rural Health Services | 1 | 2011 | 27 | 0.100 |
Why?
|
| Sex Factors | 1 | 2012 | 631 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 293 | 0.090 |
Why?
|
| Interviews as Topic | 1 | 2010 | 249 | 0.090 |
Why?
|
| Age Factors | 1 | 2012 | 1108 | 0.090 |
Why?
|
| Rural Population | 1 | 2010 | 246 | 0.080 |
Why?
|
| Drug Costs | 2 | 2018 | 42 | 0.080 |
Why?
|
| Logistic Models | 1 | 2010 | 727 | 0.080 |
Why?
|
| Educational Status | 2 | 2019 | 164 | 0.070 |
Why?
|
| Proton Pump Inhibitors | 1 | 2024 | 11 | 0.060 |
Why?
|
| Equipment Design | 2 | 2016 | 167 | 0.060 |
Why?
|
| Minority Groups | 1 | 2023 | 69 | 0.060 |
Why?
|
| Disease Management | 1 | 2023 | 114 | 0.050 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2023 | 148 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 2023 | 208 | 0.050 |
Why?
|
| Pregnancy | 1 | 2023 | 815 | 0.050 |
Why?
|
| Emulsions | 1 | 2020 | 7 | 0.050 |
Why?
|
| Soybean Oil | 1 | 2020 | 5 | 0.050 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2020 | 9 | 0.050 |
Why?
|
| Fish Oils | 1 | 2020 | 34 | 0.050 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2020 | 27 | 0.050 |
Why?
|
| Interdisciplinary Communication | 1 | 2019 | 53 | 0.040 |
Why?
|
| Problem Solving | 1 | 2019 | 27 | 0.040 |
Why?
|
| Fee-for-Service Plans | 1 | 2018 | 10 | 0.040 |
Why?
|
| Drug Utilization | 1 | 2018 | 47 | 0.040 |
Why?
|
| Medicaid | 1 | 2018 | 83 | 0.040 |
Why?
|
| Program Evaluation | 1 | 2019 | 175 | 0.040 |
Why?
|
| Continental Population Groups | 1 | 2019 | 221 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 598 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1119 | 0.040 |
Why?
|
| Random Allocation | 1 | 2017 | 213 | 0.040 |
Why?
|
| Body Burden | 1 | 2014 | 6 | 0.030 |
Why?
|
| Seafood | 1 | 2014 | 11 | 0.030 |
Why?
|
| Health Literacy | 1 | 2013 | 26 | 0.030 |
Why?
|
| Central Nervous System Stimulants | 1 | 2013 | 74 | 0.030 |
Why?
|
| Comorbidity | 1 | 2013 | 540 | 0.030 |
Why?
|
| Tape Recording | 1 | 2011 | 6 | 0.030 |
Why?
|
| Environmental Health | 1 | 2011 | 5 | 0.030 |
Why?
|
| Child Welfare | 1 | 2011 | 19 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2011 | 369 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2011 | 1305 | 0.020 |
Why?
|
| Young Adult | 1 | 2011 | 2402 | 0.020 |
Why?
|